BRIEF-EU Medicines Agency approves Bristol-Myers's myeloma treatment
January 29, 2016 at 07:14 AM EST
* Recommends approval of Bristol-Myers Squibb's myeloma treatment elotuzumab under accelerated assessment
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.